CN108260732A - A kind of nutritive cream for preventing pet dog nephrosis - Google Patents
A kind of nutritive cream for preventing pet dog nephrosis Download PDFInfo
- Publication number
- CN108260732A CN108260732A CN201710002646.7A CN201710002646A CN108260732A CN 108260732 A CN108260732 A CN 108260732A CN 201710002646 A CN201710002646 A CN 201710002646A CN 108260732 A CN108260732 A CN 108260732A
- Authority
- CN
- China
- Prior art keywords
- parts
- pet dog
- nephrosis
- oil
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 23
- 208000009928 nephrosis Diseases 0.000 title claims abstract description 23
- 231100001027 nephrosis Toxicity 0.000 title claims abstract description 23
- 230000000050 nutritive effect Effects 0.000 title claims abstract description 18
- 239000006071 cream Substances 0.000 title claims abstract description 16
- 239000010775 animal oil Substances 0.000 claims abstract description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 20
- 239000008158 vegetable oil Substances 0.000 claims abstract description 20
- 235000013372 meat Nutrition 0.000 claims abstract description 16
- 229920002472 Starch Polymers 0.000 claims abstract description 15
- 239000008107 starch Substances 0.000 claims abstract description 15
- 235000019698 starch Nutrition 0.000 claims abstract description 15
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 12
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 12
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 12
- 239000008267 milk Substances 0.000 claims abstract description 12
- 210000004080 milk Anatomy 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000006708 antioxidants Nutrition 0.000 claims description 11
- 230000003078 antioxidant effect Effects 0.000 claims description 10
- 241000251511 Holothuroidea Species 0.000 claims description 9
- 235000015278 beef Nutrition 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 7
- 241000238557 Decapoda Species 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 4
- 235000014121 butter Nutrition 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- 239000000312 peanut oil Substances 0.000 claims description 4
- 241001137251 Corvidae Species 0.000 claims description 3
- 235000015108 pies Nutrition 0.000 claims description 3
- 235000015277 pork Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 230000035764 nutrition Effects 0.000 abstract description 12
- 235000013305 food Nutrition 0.000 abstract description 10
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 description 25
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 16
- 230000003907 kidney function Effects 0.000 description 14
- 206010018364 Glomerulonephritis Diseases 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 10
- 235000021336 beef liver Nutrition 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000000885 nephron Anatomy 0.000 description 8
- 208000001647 Renal Insufficiency Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 208000020832 chronic kidney disease Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 201000006370 kidney failure Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 6
- 238000007711 solidification Methods 0.000 description 6
- 230000008023 solidification Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 210000005239 tubule Anatomy 0.000 description 5
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000001736 capillary Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000017169 kidney disease Diseases 0.000 description 4
- 239000002417 nutraceutical Substances 0.000 description 4
- 235000021436 nutraceutical agent Nutrition 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 241000143060 Americamysis bahia Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000002665 bowman capsule Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000037157 Azotemia Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010059345 Postrenal failure Diseases 0.000 description 2
- 206010072370 Prerenal failure Diseases 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 208000012998 acute renal failure Diseases 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229950007002 phosphocreatine Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 230000009103 reabsorption Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010018370 Glomerulonephritis membranoproliferative Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000004451 Membranoproliferative Glomerulonephritis Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000862632 Soja Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 230000008721 basement membrane thickening Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 201000008350 membranous glomerulonephritis Diseases 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003360 nephrocyte Anatomy 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- -1 nitrogenous compound Chemical class 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Landscapes
- Fodder In General (AREA)
Abstract
The present invention relates to a kind of nutritive cream for preventing pet dog nephrosis, raw material includes 30 40 parts of starch, 5 10 parts of vegetable oil, 5 10 parts of animal oil, 20 30 portions of meat, 10 20 portions of milk, 5 10 parts of kernels, 10 15 portions of maltose, 13 parts of antioxidants, 23 parts of L l-cns, 15 parts of phagostimulants according to mass parts.Pass through the adjustment eaten food to pet dog, ensure that pet dog nutrition in food is balanced, it can aid in the immunity for improving pet dog itself, rational nutrition cooperation can be prevented effectively during pet dog is eaten food, since nutrition is uneven or the missing of vitamin, cause pet dog that nephrosis occurs, effectively prevent pet dog renal hypofunction, the risk of nephrosis occurs.
Description
Technical field
The present invention relates to pet food formulation technical fields, specifically belong to a kind of nutritive cream for preventing pet dog nephrosis.
Background technology
Ephritis is the generic term of renal inflammation, can be focal or diffused Hypertrophic or destructive disease,
It is related to glomerulus, renal tubule or renal interstitial (or connective) tissue.Ephritis can by multiple stage developments, in late stage renal disease or
End stage renal disease terminates.The most common form of ephritis is glomerulonephritis.Glomerulonephritis or glomerulonephritis
(" GN ") is characterized the illness of the inflammation of the bead for being kidney or capillary loops.This illness is with acute, subacute and slow
Property form occur, and can be idiopathic or secondary to infection, disease or be exposed to toxin.
Kidney failure cannot keep its normal function for kidney.As a result, metabolic waste and metabolin gather in blood.These
Waste and metabolin can negatively affect most of body systems.Imbalance in terms of holding body fluid and electrolyte balance is kidney failure
The characteristics of.
Acute renal failure due to wound, infection, inflammation or can be exposed to renal toxicity substance and occur suddenly.The illness can be led
Cause dehydration, low blood pressure and circulatory failure.Acute renal failure generally falls into 3 classes：(1) pre-renal failure (pre-
Renalfailure), it is related with renal blood flow reduction；(2) failure (intra-renalfailure) in kidney, with ischemic and
Toxin is related；(3) postrenal failure (post-renalfailure) is caused by uroflow blocking.
The progressive that chronic renal failure includes renal function is lost, and can finally develop into late stage renal disease or failure.It rises
Just, chronic renal failure starts due to decreased renal function, without the apparent accumulation of metabolic waste in blood.When glomerulus is filtered
It crosses rate due to inflammation to slow down, waste starts to gather.Disease develops to uremia since renal function is low, and high-caliber egg
White final product starts to accumulate and damage body function.The common cause of chronic renal failure includes：Inflammation, infection, urinary tract infraction
And certain systemic diseases and toxicity, including hypercalcinemia, lupus erythematosus, diabetes and hypertension.
Chronic renal failure of the mark of late stage renal disease for irreversibility.Serum creatinine and blood urea nitrogen persistent levels
Raising, and the uremia generated damages all body systems.Kidney can be with the grade of about 10% or less of normal renal function
Number is lost by permanent and almost function.One reason of late stage renal disease is glomerulonephritis.Other originals
Because of those reasons for including referring to chronic renal failure.
Construction package of the glomerulus for the nephron of kidney, and by being commonly described as capillary loops
(capillarytuft) or the thin vessels of clump (cluster) are formed.The nephron is the basic structure and functional unit of kidney,
Also comprising referred to as specification 4CN105886649A4 Ma Maer Pi Jishi (malpighian) of page 1/35 or Bowman's capsule
The structure of (Bowman ' s, capsule) and include parteriole and renal tubule.Bowman's capsule contains glomerulus loop and renal tubule.
Glomerulus is very small capillary, therefore very slow by the blood flow of these blood vessels, and the molecule in blood can become
It is easy to be deposited on the wall of these tiny capillaries.Renal tubule is made of basilar memebrane and epithelial layer, and for secrete, collect and
Urethral catheterization.
Glomerulus plays filter in the nephron.Water and small molecule in blood flow through glomerulus, and pass through referred to as
The structured filter of basilar memebrane, is formed by glomerulus and Bowman's capsule.Filtrate comprising water and small molecule is inhaled by renal tubule
It receives, and by reabsorption before urine is eventually converted into.Basilar memebrane is made of the hole of all size, these holes are used to filter
Small molecule and prevent larger molecule from passing through basilar memebrane.The specific function of the nephron be from the certain end product of metabolisms of plasma removing,
Such as uric acid, urea and kreatinin and the electrolyte of excess, such as sodium, chlorine and potassium ion.Pass through reabsorption water and electrolysis
Matter, the nephron play an important role in keeping body in terms of Normal fluid balance.
Kreatinin is since sarcosine is metabolized the nitrogenous compound to be formed.Sarcosine is followed successively by vivo from 3 kinds of amino acid
The non-proteinaceous matter of (arginine, glycine and methionine) synthesis.It was found that this molecule in muscle to exist in a small amount, and
When being combined into phosphocreatine with phosphoric acid, the storage form as energy-rich phosphate, for various metabolic processes.Kreatinin is absorbed
Into blood, and finally drained in urine.Therefore, can be used for measuring for measuring the simple laboratory test of kreatinin in blood
Renal function.This test is commonly referred to as creatinine clearance test, measures the flesh from plasma clearance in given time interval
The amount of acid anhydrides.Because kreatinin is formed with relative constant amount from phosphocreatine, the creatinine levels in blood rise to kidney
The indication that dysfunction, i.e. renal function are lost.
Glomerulonephritis may occur due to the biological damage to immune system.Foreign substance can be attached to basilar memebrane
It goes up and causes immune response, antibody is caused to generate.These antibody can be combined with foreign substance, cause become to be deposited on it is small
Immune complex in glomerular capillary wall leads to the damage to the nephron.Alternatively, in some individuals, immune system
Can be produced as the autoantibody of immunoglobulin, can attack nephrocyte, lead to so-called autoimmune response.If internal
Protein changes, and autoantibody reaction may then occur, because autoantibody identifies the protein as oneself non-change.This
A little autoantibody-protein complexes can be equally deposited on the basilar memebrane of glomerulus, cause the destruction of nephron function.
Glomerulonephritis is the common cause of felid albuminuria, and can be the idiopathic or ondary forms of illness.
In the later case, illness can secondary be knurl formation, inflammatory disease, dysendocrinism, infection or familial nephrosis.As
In people, the glomerulonephritis of felid is usually what immunology mediated, the immunoglobulin and benefit being related in animal body
The body factor.The damage of the metamorphosis of glomerulus is caused to be happened in the glomerulus of kidney.Final damage is irreversible, and
Lead to the dysfunction of the nephron.
Glomerulonephritis in scientific literature with based on many different forms of the changes in histopathology just occurred come
Characteristic is described.Membranous glomerulonephritis includes glomerular basement membrane thickening.Hypertrophic or mesangial matrix *
(mesangioproliferative) feature of glomerulonephritis is cell in extracellular matrix (mesangialmatrix)
Hyperplasia.Membranoproliferative glomerulonephritis includes the combination of above-mentioned variation.The feature of glomerulosclerosis for matrix formed and
Cicatrization increases.In some cases, only slightly increase there are the minimum change of glomerulus and mesangial cell proliferation.
Many methods, such as DNA microarray, the label sequencing of expression have been developed for research differential gene expression
(EST), the serial analysis (SAGE) of gene expression, subtractive hybridization, the deduction clone of mRNA and differential display (DD), RNA- are arbitrary
It primer PCR (RAP-PCR), real-time PCR (RT-PCR), expressivity differential analysis (RDA), two-dimensional gel electrophoresis, mass spectrum and is based on
The protein microarray of antibody binding proteins.
Due to the complexity of biological approach and interaction of molecules and the intercellular signal of inherence that are related to kidney trouble
Transductive process, it is therefore highly desirable to understand occurent interaction at the genetic level.In the morning that felid renal function is lost
(dysregulated) gene that phase detection is adjusted extremely, helps to understand the biology of kidney trouble, is based especially on complete group
The glomerulonephritis of gene.Gene unconventionality, which is adjusted, to be carried out early stage being developed by the Animal diseases of ischemia injury repeatedly
The fact that detection, contribute to abnormal forfeitures designed for felid renal function, kidney failure, glomerular filtration rate reduction or
Diagnosis, design and the method for monitoring treatment plan of glomerulonephritis.
Be related to by the biological approach of gene expression profile it is more detailed understand will be helpful to diagnostic program in disease pathway,
The exploitation that reagent and test kit and beneficial drug, nutraceutical (nutraceutical) and nutrition (diet) are intervened.
These methods can enable to early detection and effectively prevent or treat potential kidney diaseases, particularly glomerular kidney
Scorching and monitoring early stage kidney failure and glomerulonephritis prognosis, especially in felid.It is related to the disease of this obstacle
Gene unconventionality adjusting of science can be used as the diagnosis of the obstacle and effectively prevent or the important biomolecule marker treated and excellent
Change the selection that suitable drug, nutraceutical and nutrition (diet) are intervened.
The horizontal measure that the level of gene expression and/or expressed gene outcome work in animal, available for selecting
The suitable drug for the treatment of or prevention property purposes.The data can select suitable drug by skilled worker, as in animal
Prevent or treat the drug of kidney trouble by gene expression profile.Gene expression data and analysis also can be by using showing kidney
The biomarker of the health status of dirty function, for selecting to mend trophic component of the kidney performance with beneficial effect, diet
Fill agent and nutraceutical.
Dog, cat kidney trouble are common internal diseases at present.With popularizing for biochemical investigation technology, judge that dog, cat are
No generation renal failure has been easier to, and discriminating is acute or chronic kidney hypofunction is particularly important in diagnosis and treatment.It is progressive due to nephrosis
Property development, eventually with renal function completely loses and it is dead, and plus on the clinical treatment of kidney trouble, simple western medical treatment also has
Many problems, particularly to chronic kidney hypofunction early stage and old case, imageological examination finds that the shape of kidney and result change,
But biochemical investigation renal function index is shown normally, in this case, since renal function still maintains to run well, so using
Prescription grain can have auxiliary compensation to the early stage of nephrosis or the body of gerontal case.
Invention content
In order to overcome the disadvantages of the above prior art, the object of the present invention is to provide a kind of immunological regulation energy for enhancing pet
Power, during to pet dog feeding, the food eaten by pet dog is protected come the renal function to pet dog, prevention
The nutritive cream of the prevention pet dog nephrosis of nephrosis occurs.
In order to achieve the above objectives, the present invention is using following technical scheme, a kind of nutritive cream for preventing pet dog nephrosis, original
Material according to mass parts include 30-40 parts of starch, 5-10 parts of vegetable oil, 5-10 parts of animal oil, 20-30 portions of meat, 10-20 portions of milk,
5-10 parts of kernels, 10-15 portions of maltose, 1-3 parts of antioxidants, 2-3 parts of L- l-cns, 1-5 parts of phagostimulants.
The starch is one or several kinds of combinations in corn flour, analysis for soybean powder or yam flour.
The vegetable oil is one or several kinds of combinations in peanut oil, corn oil or oleum sojae.
The animal oil is butter or sheep oil.
The pork pies include beef liver, ham, shrimp, beef, mutton and sea cucumber, and weight ratio is 2:2:1:2:2:1.
Its raw material includes 35 parts of starch, 8 parts of vegetable oil, 7 parts of animal oil, 25 parts of meat, 15 parts of milk, kernel according to mass parts
7 parts, 13 parts of maltose, 2 parts of antioxidant, 2.5 parts of L- l-cns, 3 parts of phagostimulant.
The beneficial effects of the invention are as follows：By the adjustment eaten food to pet dog, ensure that pet dog nutrition in food is balanced,
The immunity for improving pet dog itself is can aid in, rational nutrition cooperation can effectively prevent the mistake eaten food in pet dog
Cheng Zhong since nutrition is uneven or the missing of vitamin, causes pet dog that nephrosis occurs, pet dog renal function is effectively prevented to subtract
It moves back, the risk of nephrosis occurs.
Specific embodiment
The present invention is described in detail with reference to embodiment.
A kind of nutritive cream of prevention pet dog nephrosis of the present invention, raw material include 30-40 parts of starch, 5- according to mass parts
10 parts of vegetable oil, 5-10 parts of animal oil, 20-30 portions of meat, 10-20 portions of milk, 5-10 parts of kernels, 10-15 portions of maltose, 1-3 parts
Antioxidant, 2-3 parts of L- l-cns, 1-5 parts of phagostimulants.
Starch is mainly carbohydrate, can be that the daily of pet dog provides certain heat and sugar, and without egg
White matter effectively avoids pet dog and takes in a large amount of protein in food, kidney is caused to bear；Mainly using corn
One or several kinds of combinations in powder, analysis for soybean powder or yam flour；It, can containing a large amount of heat in vegetable oil and animal oil
Meet the daily required heat of pet dog simultaneously, containing a large amount of aliphatic acid in vegetable oil and animal oil, animal can synthesize required
Saturated fatty acid and this kind of unrighted acid containing only 1 double bond of oleic acid, more double bonds containing 2 or 2 or more double bonds
Aliphatic acid must then be obtained from plant, therefore the latter is known as essential fatty acid, and wherein linolenic and linoleic is most important.Peanut four
Olefin(e) acid is generated from linoleic acid.Arachidonic acid is the precursor of most of prostaglandins, and prostaglandin can adjust cell function
Hormonelike substance；Vegetable oil is mainly using one or several kinds of combinations in peanut oil, corn oil or oleum sojae, animal
Oil uses butter or sheep oil meat that can provide a certain amount of protein intake for pet dog, simultaneously containing a large amount of compound dimension life
Element supplements the vitamin in pet dog, while can increase the appetite of pet dog；Pork pies include beef liver, ham, shrimp, beef, mutton
And sea cucumber, and weight ratio is 2:2:1:2:2:1.
The main main Physiological Function of L- l-cns be promote adipose conversion into energy, taking l-cn can reduced
While body fat, losing weight, moisture and muscle are not reduced, pet is avoided and reduces movement in convalescence, cause to get fat,
Weight increases, and influences to reply, while other diseases occur.
Preservative mainly prevents nutritive cream from going bad in a short time, generates mushroom, pet is damaged, in the present invention
Used preservative is all food preservative.
Embodiment 1
(1) its raw material, 30 parts of starch (yam flour), 5 parts of vegetable oil (peanut oil), 5 parts of animal oil are matched according to mass ratio
(sheep oil), 20 portions of meat (4 parts of beef livers, 4 portions of hams, 2 portions of shrimps, 4 parts of beef, 4 portions of mutton, 2 portions of sea cucumbers), 10 portions of milk, 5 portions of fruits
Benevolence, 10 portions of maltose, 1 part of antioxidant, 2 parts of L- l-cns, 1 part of phagostimulant；
(2) beef liver, ham, shrimp, beef, mutton, sea cucumber are put into meat grinder and blended, then added to the meat blended is interior
Enter starch, antioxidant, L- l-cns and phagostimulant, and be stirred, while inwardly add in vegetable oil and milk and stir
Uniformly；
(3) uniform article is completed into stirring in step (2), stands 4 hours；
(4) article after being stood in step (3) forms glue, and the gelatinous article then is fabricated to various moulds
Type, after the completion for the treatment of modelling, coats animal oil at (such as bone pet dog compares the model of hobby) on model；
(5) after coating animal oil, 2 hours are being stood, after band vegetable oil is fully immersed into, kernel is spread to model
Then maltose is coated to the surface of kernel, and stands 12 hours by surface, band solidification completely；
(6) it by the article after solidification in step (5), is sterilized using magnetic force method for disinfection.
(7) it encapsulates.
Embodiment 2
1) its raw material is matched according to mass ratio, including 35 parts of starch (corn flour), vegetable oil 8 parts (corn oils), animal oil 7
Part (sheep oil), 25 parts of meat (5 parts of beef livers, 5 portions of hams, 2.5 portions of shrimps, 5 parts of beef, 5 portions of mutton, 2.5 portions of sea cucumbers)), 15 parts of milk,
7 parts of kernel, 13 parts of maltose, 2 parts of antioxidant, 2.5 parts of L- l-cns, 3 parts of phagostimulant；
(2) beef liver, ham, shrimp, beef, mutton, sea cucumber are put into meat grinder and blended, then added to the meat blended is interior
Enter starch, antioxidant, L- l-cns and phagostimulant, and be stirred, while inwardly add in vegetable oil and milk and stir
Uniformly；
(3) uniform article is completed into stirring in step (2), stands 6 hours；
(4) article after being stood in step (3) forms glue, and the gelatinous article then is fabricated to various moulds
Type, after the completion for the treatment of modelling, coats animal oil at (such as bone pet dog compares the model of hobby) on model；
(5) after coating animal oil, 3 hours are being stood, after band vegetable oil is fully immersed into, kernel is spread to model
Then maltose is coated to the surface of kernel, and stands 12 hours by surface, band solidification completely；
(6) it by the article after solidification in step (5), is sterilized using magnetic force method for disinfection.
(7) it encapsulates.
Embodiment 3
Its raw material is matched according to mass ratio, including 40 parts of starch (analysis for soybean powder), vegetable oil 10 parts (oleum sojaes), animal oil 10
Part (5 parts of sheep oil, 5 parts of butter), 30 parts of meat (6 parts of beef livers, 6 portions of hams, 3 portions of shrimps, 6 parts of beef, 6 portions of mutton, 3 portions of sea cucumbers)), ox
20 parts of milk, 10 parts of kernel, 15 parts of maltose, 3 parts of antioxidant, 3 parts of L- l-cns, 5 parts of phagostimulant；
(2) beef liver, ham, shrimp, beef, mutton, sea cucumber are put into meat grinder and blended, then added to the meat blended is interior
Enter starch, antioxidant, L- l-cns and phagostimulant, and be stirred, while inwardly add in vegetable oil and milk and stir
Uniformly；
(3) uniform article is completed into stirring in step (2), stands 6 hours；
(4) article after being stood in step (3) forms glue, and the gelatinous article then is fabricated to various moulds
Type, after the completion for the treatment of modelling, coats animal oil at (such as bone pet dog compares the model of hobby) on model；
(5) after coating animal oil, 3 hours are being stood, after band vegetable oil is fully immersed into, kernel is spread to model
Then maltose is coated to the surface of kernel, and stands 12 hours by surface, band solidification completely；
(6) it by the article after solidification in step (5), is sterilized using magnetic force method for disinfection.
(7) it encapsulates.
The ingredient of nutritive cream in above-described embodiment is tested, test result is as follows：
| Nutritive index | Per hectogram content | Nutritive index | Per hectogram content |
| Thick protein | >=22% | Crude fat | >=10% |
| Vitamin A | ≥2100IU | Vitamin B2 | ≥18mg |
| Vitamin C | ≥400mg | Vitamin D | ≥4000IU |
| P elements | ≤40mg | Sodium chloride | >=1.0% |
| Sugar | ≥30g | Flavonoids | ≥500g |
The rich in nutrition content of nutritive cream that this above-described embodiment provided is can be seen that from upper table, fully meets pet
Cat and the required nutritional ingredient of dog.
Clinical results
By the way that nephrosis illness convalescent pet dog feeding observation, (this clinical verification uses convalescent pet dog, is
Verification can be accurately obtained, such as inaccurate using the data of normal pet dog clinical verification, it may appear that deviation), 100%
Case receives, wherein 80% case compares eating, increases 1%-1.5% with average weight after this product 1 month, in ± 5% model
It in enclosing, can be eaten for a long time, the urination of 9% case has restored normal, some improvements of 54% case, 39% case drinking-water
Amount restores normal, some improvements of 54% case, the molding of 100% defecation, wherein 71% is neither too hard, nor too soft, without phenomenon of having loose bowels, 39%
The urination of case has restored normal, and 54% case some improvements animal doctor thinks that this product is suitble to the conditioning of chronic kidney disease.
Compared with prior art, pet dog kidney trouble nutrition grain has limit standard in the setting level of nutrient, mainly
It shows：Not by the food materials for the specific nutrition element for having early stage maintenance function to nephrosis and naturally can forage plant component it is special
The case that grain combines uses.The technology of the present invention is while pet dog vital movement demand is met, for pet dog kidney trouble
The symptom feature of early stage is started with from the nutrition dietary for the normal operation for safeguarding renal function, by specific nutrient with can naturally raise
It is compounded with plant, becomes the proprietary formula for the recovering aid conditioning for specializing in kidney trouble early stage pet dog nutritional support, clinical verification
Show that the technology of the present invention is effective to the maintenance of pet dog kidney trouble rehabilitation health.
The foregoing examples are only illustrative of the present invention, does not form the limitation to protection scope of the present invention, all
Be with the present invention it is the same or similar design all belong to the scope of protection of the present invention within.
Claims (6)
1. it is a kind of prevent pet dog nephrosis nutritive cream, which is characterized in that its raw material according to mass parts include 30-40 parts of starch,
5-10 parts of vegetable oil, 5-10 parts of animal oil, 20-30 portions of meat, 10-20 portions of milk, 5-10 parts of kernels, 10-15 parts of maltose, 1-3
Part antioxidant, 2-3 parts of L- l-cns, 1-5 parts of phagostimulants.
2. a kind of nutritive cream for preventing pet dog nephrosis according to claim 1, it is characterised in that：The starch is beautiful
One or several kinds of combinations in rice flour, analysis for soybean powder or yam flour.
3. a kind of nutritive cream for preventing pet dog nephrosis according to claim 1, which is characterized in that the vegetable oil is
One or several kinds of combinations in peanut oil, corn oil or oleum sojae.
4. a kind of nutritive cream for preventing pet dog nephrosis according to claim 1, which is characterized in that the animal oil is
Butter or sheep oil.
5. a kind of nutritive cream for preventing pet dog nephrosis according to claim 1, which is characterized in that the pork pies include ox
Liver, ham, shrimp, beef, mutton and sea cucumber, and weight ratio is 2:2:1:2:2:1.
6. according to the nutritive cream of any one prevention pet dog nephrosis of claim 1-5, which is characterized in that its raw material is according to quality
Part include 35 parts of starch, 8 parts of vegetable oil, 7 parts of animal oil, 25 parts of meat, 15 parts of milk, 7 parts of kernel, 13 parts of maltose, anti-oxidant
2 parts of agent, 2.5 parts of L- l-cns, 3 parts of phagostimulant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710002646.7A CN108260732A (en) | 2017-01-03 | 2017-01-03 | A kind of nutritive cream for preventing pet dog nephrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710002646.7A CN108260732A (en) | 2017-01-03 | 2017-01-03 | A kind of nutritive cream for preventing pet dog nephrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108260732A true CN108260732A (en) | 2018-07-10 |
Family
ID=62770621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710002646.7A Pending CN108260732A (en) | 2017-01-03 | 2017-01-03 | A kind of nutritive cream for preventing pet dog nephrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108260732A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109430545A (en) * | 2018-12-18 | 2019-03-08 | 日照职业技术学院 | A kind of pet nutrition cream prepared using arctic sweet tea shrimp processing byproduct |
| CN112262928A (en) * | 2020-09-01 | 2021-01-26 | 上海耐威克宠物用品有限公司 | Nutrient paste beneficial to dog urinary system and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101132700A (en) * | 2004-12-29 | 2008-02-27 | 希尔氏宠物营养品公司 | Compositions and methods for improving kidney function |
| CN101287460A (en) * | 2005-08-17 | 2008-10-15 | 希尔氏宠物营养品公司 | Methods and compositions for the preventioin and treatment of kidney disease |
| CN103385352A (en) * | 2013-07-17 | 2013-11-13 | 江苏绿茵生物科技有限公司 | Pet food |
| CN105705146A (en) * | 2013-11-05 | 2016-06-22 | 希尔氏宠物营养品公司 | Methods and compositions for improving kidney function |
-
2017
- 2017-01-03 CN CN201710002646.7A patent/CN108260732A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101132700A (en) * | 2004-12-29 | 2008-02-27 | 希尔氏宠物营养品公司 | Compositions and methods for improving kidney function |
| CN101287460A (en) * | 2005-08-17 | 2008-10-15 | 希尔氏宠物营养品公司 | Methods and compositions for the preventioin and treatment of kidney disease |
| CN103385352A (en) * | 2013-07-17 | 2013-11-13 | 江苏绿茵生物科技有限公司 | Pet food |
| CN105705146A (en) * | 2013-11-05 | 2016-06-22 | 希尔氏宠物营养品公司 | Methods and compositions for improving kidney function |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109430545A (en) * | 2018-12-18 | 2019-03-08 | 日照职业技术学院 | A kind of pet nutrition cream prepared using arctic sweet tea shrimp processing byproduct |
| CN112262928A (en) * | 2020-09-01 | 2021-01-26 | 上海耐威克宠物用品有限公司 | Nutrient paste beneficial to dog urinary system and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hafez et al. | The impact of curcumin on growth performance, growth-related gene expression, oxidative stress, and immunological biomarkers in broiler chickens at different stocking densities | |
| RU2412608C2 (en) | Fodder composition for prophylactics of kidney diseases, its production method, kidney diseases prophylactics method, set | |
| Escudero et al. | Characterization of peptides released by in vitro digestion of pork meat | |
| RU2518455C2 (en) | Pyruvat compounds for domestic animals and methods for using them | |
| Gruys et al. | Monitoring health by values of acute phase proteins | |
| RU2727670C1 (en) | Pet food compositions | |
| Martinez et al. | Bioactive compounds in cod (Gadus morhua) products and suitability of 1H NMR metabolite profiling for classification of the products using multivariate data analyses | |
| Premi et al. | Changes of plasma analytes reflecting metabolic adaptation to the different stages of the lactation cycle in healthy multiparous Holstein dairy cows raised in high-welfare conditions | |
| Schop et al. | Increasing intake of dietary soluble nutrients affects digesta passage rate in the stomach of growing pigs | |
| Pandey et al. | Ambient stress associated variations in metabolic responses of Marwari goat of arid tracts in India | |
| Mundim et al. | Influence of age and sex on the serum biochemical profile of Doberman dogs in the growth phase | |
| Olivera-Castillo et al. | Diets containing sea cucumber (Isostichopus badionotus) meals are hypocholesterolemic in young rats | |
| Wang et al. | Pigeon during the breeding cycle: behaviors, composition and formation of crop milk, and physiological adaptation | |
| El Malik et al. | Changes in lipid profile and heart tissues of wistar rats induces by using monosodium glutamate as food additive | |
| Blasi et al. | Grape pomace for feed enrichment to improve the quality of animal-based foods | |
| CN108260732A (en) | A kind of nutritive cream for preventing pet dog nephrosis | |
| Poleksić et al. | Morphological and physiological evaluation of common carp (Cyprinus carpio L., 1758) fed extruded compound feeds containing different fat levels | |
| Zhang et al. | The effect of replacing whole-plant corn silage with daylily on the growth performance, slaughtering performance, muscle amino acid composition, and blood composition of tan sheep | |
| Gursoy et al. | The effects of apricot on serum proteins and liver enzymes in rats | |
| Ihuţ et al. | Seasonal variation of blood biomarkers in huchen, Hucho hucho (Actinopterygii: Salmoniformes: Salmonidae) reared in captivity | |
| Ölmez et al. | Effect of SOD-Rich Melon supplement on performance, serum biochemical, antioxidant and meat quality characteristics of Tuj lambs | |
| de Nicola et al. | Milk metabolomics reveals potential biomarkers for early prediction of pregnancy in buffaloes having undergone artificial insemination | |
| Kabasakal Cetin et al. | Maternal low quality protein diet alters plasma amino acid concentrations of weaning rats | |
| Aparicio et al. | Whey versus soy protein diets and renal status in rats | |
| Silva et al. | Different concentrations of protein and fresh mango as a carbohydrate source in the tambaqui diet (Colossoma macropomum) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180710 |